Hematological complications of chronic HCV infection and its treatment / Fatma Mohamed Essam Eldin ; Supervised Naglaa Ali Zayed , Rabab Mamoum Salama
Material type:
- المضاعفات الدموية للالتهاب الكبدي الفيروسي س و علاجاتة [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.33.M.Sc.2012.Fa.H (Browse shelf(Opens below)) | Not for loan | 01010110058479000 | ||
![]() |
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.33.M.Sc.2012.Fa.H (Browse shelf(Opens below)) | 58479.CD | Not for loan | 01020110058479000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | ||
Cai01.11.33.M.Sc.2012.Do.E Evaluation of the clinical utility of alpha feto protein - L₃ in the diagnosis of hepatocelluler carcinoma / | Cai01.11.33.M.Sc.2012.Do.E Evaluation of the clinical utility of alpha feto protein - L₃ in the diagnosis of hepatocelluler carcinoma / | Cai01.11.33.M.Sc.2012.Fa.H Hematological complications of chronic HCV infection and its treatment / | Cai01.11.33.M.Sc.2012.Fa.H Hematological complications of chronic HCV infection and its treatment / | Cai01.11.33.M.Sc.2012.Ha.T Tuberculosis as a re-emerging disease / | Cai01.11.33.M.Sc.2012.Ha.T Tuberculosis as a re-emerging disease / | Cai01.11.33.M.Sc.2012.Ka.V Virological breakthrough in chronic HBV Egyptian patients receiving lamivudine therapy / |
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Tropical Medicine
Hepatitus C virus (HCV) infection has been reported to cause many extrahepatic complications including hematological complications such as anemia, thrombocytopenia and leucopenia. Interferon-based regimens were reported to induce high incidence of hematological side effects with eventual dose reduction in 40% of patients with consequent 10-20% reductions in the virological responses achieved
Issued also as CD
There are no comments on this title.